Background Allergen exposure chambers (AEC s) are clinical facilities allowing for
controlled exposure of subjects to allergens in an enclosed environment. AEC s have …

Aeroallergens occur naturally in the environment and are widely dispersed across Canada,
yet their public health implications are not well-understood. This review intends to provide a …

Background Pollen variation can affect field study data quality. Nasal allergen challenge
(NAC) is considered the gold standard for evaluating allergic rhinitis, while environmental …

Background Synthetic peptide immunoregulatory epitopes are a new class of
immunotherapy to treat allergic rhinoconjunctivitis (ARC). Grass allergen peptides …

Background Epigenetic alterations may represent new therapeutic targets and/or biomarkers
of allergic rhinitis (AR). Our aim was to examine genome‐wide epigenetic changes induced …

Allergen exposure chambers (AECs) have been developed for controlled allergen
challenges of allergic patients mimicking natural exposure. As such, these facilities have …

Background Allergic rhinitis is an inflammatory disease that causes cellular influx and
mediator release in the nose. These inflammatory changes might be used as nasal …

Purpose This study aimed to develop a hyperosmolar, barrier-forming nasal spray based on
carrageenan and sorbitol, and to demonstrate its decongestant effect in the context of …

Background Timothy grass pollen allergen extract tablets (Grastek) are standardized
sublingual immunotherapy tablets (SLIT-T) approved for the treatment of grass pollen …

Objective To summarize studies highlighting recent advances in rhinitis-related research in
the past 2 years. Data Sources Original research articles were procured and examined from …